- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Notice of 2024 Annual General Meeting
- Audited Preliminary Results 2024
- Commencement of Phase III Paediatric Trial
- Update on funding
- Update on funding and preliminary results
- Progression of patient cohorts in PROTECT Trial
- Trading update for the year ended 30 June 2024
- Appointment of Nominated Adviser and Sole Broker
- Launch of new Company Long Term Incentive Plan
- Appointment of Non-Executive Director
More ▼
Key statistics
As of last trade Allergy Therapeutics PLC (AGY:LSE) traded at 5.20, -17.46% below its 52-week high of 6.30, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.25 |
---|---|
High | 5.30 |
Low | 5.20 |
Bid | 5.00 |
Offer | 5.50 |
Previous close | 5.20 |
Average volume | 417.30k |
---|---|
Shares outstanding | 4.77bn |
Free float | 334.69m |
P/E (TTM) | -- |
Market cap | 247.85m GBP |
EPS (TTM) | -0.0107 GBP |
Data delayed at least 20 minutes, as of Nov 22 2024 11:00 GMT.
More ▼